Canada’s first psilocybin legislation: Thomas’ Bill C-286
Meet MP Corey Tochor and learn about his motivation for introducing Thomas’ Bill, its impact on patients and the health care system from a patient and other experts.
Join us to learn about MP Tochor’s motivation for introducing Thomas’ Bill and its impact on patient access and the health care system.
Canada’s first psilocybin legislation: Thomas’ Bill C-286
Corey Tochor, MP, Saskatoon-University
Steve Allgood, brain cancer survivor and psychedelic advocate
Jagpaul Kaur Deol, Board Member, MAPS Canada
Rielle Capler, Executive Director, MAPS Canada
Reverdi Darda, Board Chair, MAPS Canada
The purpose and impact of Thomas' Bill (Bill C-286)
What the proposed legislation means for patients, practitioners, and researchers
How this impacts the future of regulated psychedelic-assisted therapies in Canada
How advocates and Canadians can support evidence-based policy reform